Press / media

A new branch of the Fraunhofer IZI was established in Würzburg at the beginning of 2024. Under the direction of Prof. Dr. Michael Hudecek, new technologies for cellular immunotherapies for the treatment of various cancers are being developed and clinically tested.

In her doctoral thesis, Dr. Susann Allelein from the Fraunhofer Institute for Cell Therapy and Immunology IZI investigated a new approach for the early detection of prostate cancer in particular. She was awarded the 3rd Hugo Geiger Prize 2023 on February 28, 2024. The prize, awarded by the Free State of Bavaria and the Fraunhofer-Gesellschaft, recognizes outstanding, application-oriented doctoral theses.

The JOIN4ATMP project was launched in January. The project aims to help accelerate the development and broad availability of novel therapies in Europe. The Fraunhofer Institute for Cell Therapy and Immunology IZI is one of the 14 project partners from 9 countries.

What influence do changes in land use and a loss of biodiversity have on the transmission of pathogens between animals and humans? This question is being investigated by an international and interdisciplinary research team as part of the EU project ZOE - "Zoonosis Emergence accros Degraded and Restored Forest Ecosystems". Partners from seven European and four American countries are participating in the project, which is led by Charité - Universitätsmedizin Berlin. The Fraunhofer Institute for Cell Therapy and Immunology IZI is contributing its expertise in the field of virology and assay development.